Landscapes / Companies
Precigen, Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials · 3 checked
Trials
6 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Gene therapy substances |
Approved | 2 Dec 2027Phase 4 trial completes | |||
| How it works | A gene therapy | ||||
| Next date | 2 Dec 2027 · Phase 4 trial completes | ||||
| Also tested for | Recurrent Respiratory Papillomatosis, Papillomavirus Infections and 4 more | ||||
| Open drug page | |||||
PRGN-2009not checked |
— |
Phase 2 | — | ||
| Also tested for | Cervical Cancer, HPV-Related Carcinoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma and 32 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Acute Myeloid Leukemia, Myelodysplastic Syndromes | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021